[Form 4] Lumentum Holdings Inc. Insider Trading Activity
Lumentum (NASDAQ:LITE) filed a Form 4 revealing director Alan S. Lowe sold 20,000 common shares on 06/26/2025 at $93.47, generating roughly $1.87 million. The trade, executed under a Rule 10b5-1 plan adopted 11/20/2024, reduced his direct stake by about 8% to 230,471 shares.
No derivative transactions were reported. While pre-scheduled, the sale size exceeds materiality thresholds and may influence investor sentiment.
Lumentum (NASDAQ:LITE) ha presentato un Modulo 4 che rivela che il direttore Alan S. Lowe ha venduto 20.000 azioni ordinarie il 26/06/2025 a $93,47, generando circa 1,87 milioni di dollari. L'operazione, eseguita nell'ambito di un piano Rule 10b5-1 adottato il 20/11/2024, ha ridotto la sua partecipazione diretta di circa l'8%, portandola a 230.471 azioni.
Non sono state segnalate transazioni derivate. Sebbene programmata in anticipo, la dimensione della vendita supera le soglie di rilevanza e potrebbe influenzare il sentiment degli investitori.
Lumentum (NASDAQ:LITE) presentó un Formulario 4 que revela que el director Alan S. Lowe vendió 20,000 acciones comunes el 26/06/2025 a $93.47, generando aproximadamente $1.87 millones. La operación, ejecutada bajo un plan Rule 10b5-1 adoptado el 20/11/2024, redujo su participación directa en alrededor del 8%, quedando en 230,471 acciones.
No se reportaron transacciones derivadas. Aunque fue una venta programada, el tamaño de la operación supera los umbrales de materialidad y podría influir en el sentimiento de los inversores.
Lumentum (NASDAQ:LITE)은(는) 이사 Alan S. Lowe가 2025년 6월 26일에 20,000주 보통주를 주당 $93.47에 매도하여 약 187만 달러를 창출했다고 신고한 Form 4를 제출했습니다. 이 거래는 2024년 11월 20일에 채택된 Rule 10b5-1 계획에 따라 실행되었으며, 그의 직접 지분을 약 8% 감소시켜 230,471주가 되었습니다.
파생상품 거래는 보고되지 않았습니다. 사전에 계획된 거래이지만, 매도 규모가 중요성 기준을 초과하여 투자자 심리에 영향을 미칠 수 있습니다.
Lumentum (NASDAQ:LITE) a déposé un formulaire 4 révélant que le directeur Alan S. Lowe a vendu 20 000 actions ordinaires le 26/06/2025 au prix de 93,47 $, générant environ 1,87 million de dollars. La transaction, réalisée dans le cadre d’un plan Rule 10b5-1 adopté le 20/11/2024, a réduit sa participation directe d’environ 8 %, la portant à 230 471 actions.
Aucune transaction dérivée n’a été signalée. Bien que la vente ait été programmée à l’avance, son volume dépasse les seuils de matérialité et pourrait influencer le sentiment des investisseurs.
Lumentum (NASDAQ:LITE) reichte ein Formular 4 ein, das offenlegt, dass Direktor Alan S. Lowe am 26.06.2025 20.000 Stammaktien zu je $93,47 verkauft hat und dabei rund 1,87 Millionen Dollar einnahm. Der Handel wurde im Rahmen eines am 20.11.2024 eingeführten Rule 10b5-1 Plans durchgeführt und verringerte seinen direkten Anteil um etwa 8 % auf 230.471 Aktien.
Es wurden keine Derivatgeschäfte gemeldet. Obwohl der Verkauf vorab geplant war, überschreitet das Volumen die Wesentlichkeitsschwellen und könnte die Anlegerstimmung beeinflussen.
- None.
- Director Alan S. Lowe sold 20,000 shares (~8% of his holdings) for approximately $1.87 million, potentially signaling cautious sentiment despite 10b5-1 scheduling.
Insights
Director's $1.87 M 10b5-1 sale trims stake 8%; signal modest, watch earnings for confirmation.
The 20,000-share disposition equals ~8% of Lowe’s holdings and crosses the $1 M significance bar. Because the sale is governed by a pre-arranged Rule 10b5-1 plan, informational content is muted versus discretionary selling. Still, a nearly $2 M cash-out can pressure short-term sentiment in a momentum-sensitive optical components sector. Lowe retains 230,471 shares, suggesting continued alignment. Absent other insiders joining in or soft near-term guidance, I view the transaction as a neutral data point rather than a forward indicator of deteriorating fundamentals.
Material insider sale disclosed under enhanced 10b5-1 rules; optics mildly negative.
The filing satisfies the SEC’s updated 10b5-1 disclosure checkboxes, supporting procedural integrity. However, a near-$2 M sale by a sitting director can attract scrutiny from proxy advisers, especially if accompanied by equity award refreshes or lagging TSR. Lowe’s remaining 230k-share stake still aligns his interests with shareholders, tempering concern. From a governance standpoint the transaction is properly transparent, yet the sheer size may weigh on perception until new performance data arrive.
Lumentum (NASDAQ:LITE) ha presentato un Modulo 4 che rivela che il direttore Alan S. Lowe ha venduto 20.000 azioni ordinarie il 26/06/2025 a $93,47, generando circa 1,87 milioni di dollari. L'operazione, eseguita nell'ambito di un piano Rule 10b5-1 adottato il 20/11/2024, ha ridotto la sua partecipazione diretta di circa l'8%, portandola a 230.471 azioni.
Non sono state segnalate transazioni derivate. Sebbene programmata in anticipo, la dimensione della vendita supera le soglie di rilevanza e potrebbe influenzare il sentiment degli investitori.
Lumentum (NASDAQ:LITE) presentó un Formulario 4 que revela que el director Alan S. Lowe vendió 20,000 acciones comunes el 26/06/2025 a $93.47, generando aproximadamente $1.87 millones. La operación, ejecutada bajo un plan Rule 10b5-1 adoptado el 20/11/2024, redujo su participación directa en alrededor del 8%, quedando en 230,471 acciones.
No se reportaron transacciones derivadas. Aunque fue una venta programada, el tamaño de la operación supera los umbrales de materialidad y podría influir en el sentimiento de los inversores.
Lumentum (NASDAQ:LITE)은(는) 이사 Alan S. Lowe가 2025년 6월 26일에 20,000주 보통주를 주당 $93.47에 매도하여 약 187만 달러를 창출했다고 신고한 Form 4를 제출했습니다. 이 거래는 2024년 11월 20일에 채택된 Rule 10b5-1 계획에 따라 실행되었으며, 그의 직접 지분을 약 8% 감소시켜 230,471주가 되었습니다.
파생상품 거래는 보고되지 않았습니다. 사전에 계획된 거래이지만, 매도 규모가 중요성 기준을 초과하여 투자자 심리에 영향을 미칠 수 있습니다.
Lumentum (NASDAQ:LITE) a déposé un formulaire 4 révélant que le directeur Alan S. Lowe a vendu 20 000 actions ordinaires le 26/06/2025 au prix de 93,47 $, générant environ 1,87 million de dollars. La transaction, réalisée dans le cadre d’un plan Rule 10b5-1 adopté le 20/11/2024, a réduit sa participation directe d’environ 8 %, la portant à 230 471 actions.
Aucune transaction dérivée n’a été signalée. Bien que la vente ait été programmée à l’avance, son volume dépasse les seuils de matérialité et pourrait influencer le sentiment des investisseurs.
Lumentum (NASDAQ:LITE) reichte ein Formular 4 ein, das offenlegt, dass Direktor Alan S. Lowe am 26.06.2025 20.000 Stammaktien zu je $93,47 verkauft hat und dabei rund 1,87 Millionen Dollar einnahm. Der Handel wurde im Rahmen eines am 20.11.2024 eingeführten Rule 10b5-1 Plans durchgeführt und verringerte seinen direkten Anteil um etwa 8 % auf 230.471 Aktien.
Es wurden keine Derivatgeschäfte gemeldet. Obwohl der Verkauf vorab geplant war, überschreitet das Volumen die Wesentlichkeitsschwellen und könnte die Anlegerstimmung beeinflussen.